Award
Wisconsin Department of Veterans Affairs 5I01BX003916-06
Administration of intratumoral immunocytokine to activate immune rejection of spontaneous canine melanoma
Recipient
Veterans Affairs (VA)
Awarded
April 01, 2026
Identifier
5I01BX003916-06
Award for research on intratumoral immunocytokine treatment in canine melanoma to guide human melanoma therapies, funded by Veterans Affairs with an award notice in April 2026.
Description
This project involves testing intratumoral immunocytokine (hu14.18-IL2) in canine melanoma models, with potential translation to human melanoma treatment. It is funded by the Veterans Affairs and is scheduled for award notice in April 2026. The project aims to evaluate toxicity, immunogenicity, and antitumor activity, and to identify biomarkers for response.